宇信科技(300674.SZ):終止公開發行可轉債事項並撤回申請文件
格隆匯5月20日丨宇信科技(300674.SZ)公佈,公司於2020年5月20日召開第二屆董事會第十七次會議及第二屆監事會第十一次會議,分別審議通過了《關於終止公司公開發行可轉換公司債券事項並撤回申請文件的議案》,同意公司終止公開發行可轉換公司債券事項並向中國證監會申請撤回相關申請文件,
鑑於公司經營戰略及資本安排的調整,經公司董事會認真研究,擬調整公司資本運作計劃,暫緩公開發行可轉換公司債券事宜,並根據《中華人民共和國公司法》、《中華人民共和國證券法》及中國證監會《創業板上市公司證券發行管理暫行辦法》等法律法規及規範性文件的規定,公司將向中國證監會撤回相關申請文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.